Imidazole compound and liposome containing same

US9795566B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9795566-B2
Application numberUS-201715406050-A
CountryUS
Kind codeB2
Filing dateJan 13, 2017
Priority dateJul 17, 2014
Publication dateOct 24, 2017
Grant dateOct 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided are a novel imidazole compound which has a high stability of the compound itself; and a novel imidazole compound which is useful as a membrane-constituting lipid of liposomes. Disclosed are a compound represented by the following General Formula (1), and a liposome containing the same compound. In the formula, Z is an imidazolyl group which may be substituted, L 1 is an alkylene group having 1 to 4 carbon atoms which may be substituted, X is an oxygen atom or a nitrogen-containing substituent, n is an integer of 2 to 4, m is an integer of 1 to 20, L 2 is a divalent linking group having 1 to 6 carbon atoms, Y is a nitrogen-containing group, R 1 and R 2 are a hydrogen group or an alkyl group having 1 to 6 carbon atoms, R 3 is a hydrogen atom or a substituent, and R 4 and R 5 are an alkyl group having 1 to 40 carbon atoms.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound represented by the following General Formula (1): in Formula (1), Z is an imidazolyl group which may have a substituent, L 1 is an alkylene group having 1 to 4 carbon atoms which may have a substituent, and X is an oxygen atom or a group represented by the following Formula (2), * is a position of bonding, n is an integer of 2 to 4, m is an integer of 1 to 20, L 2 is a divalent linking group having 1 to 6 carbon atoms, and Y is a group represented by the following Formula (3), R 1 and R 2 are the same or different and are a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R 3 is a hydrogen atom or a substituent, and R 4 and R 5 are the same or different and are an alkyl group having 1 to 40 carbon atoms. 2. The compound according to claim 1 , wherein L 1 is an alkylene group represented by the following Formula (4): in the formula, * represents a position of bonding. 3. A liposome comprising the compound according to claim 1 . 4. A liposome comprising the compound according to claim 2 .

Assignees

Inventors

Classifications

  • A61K9/1272Primary

    comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers (lipids as modifying agents {A61K47/543}) · CPC title

  • Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones · CPC title

  • C07D233/64Primary

    with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine · CPC title

  • Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant · CPC title

  • General methods applicable to biologically active non-coding nucleic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9795566B2 cover?
Provided are a novel imidazole compound which has a high stability of the compound itself; and a novel imidazole compound which is useful as a membrane-constituting lipid of liposomes. Disclosed are a compound represented by the following General Formula (1), and a liposome containing the same compound. …
Who is the assignee on this patent?
Fujifilm Corp
What technology area does this patent fall under?
Primary CPC classification A61K9/1272. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).